Refresh

Natco Pharma Ltd. - Research Center

524816 NATCOPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Jun' 24 Mar' 24 Dec' 23 Sep' 23 Jun' 23

Sales

1,236.90 964.80 625.30 930.50 1,048.30

Operating profit

763.00 452.70 238.30 442.30 503.70

Interest

4.40 4.50 3.80 3.00 3.20

Gross profit

798.40 484.10 264.00 464.00 515.10

EPS (Rs)

35.55 19.50 10.73 20.12 22.64
Quarterly  results in details
Jun' 24 Mar' 24 Dec' 23 Sep' 23 Jun' 23

Other income

39.80 35.90 29.50 24.70 14.60

Stock adjustment

-13.40 -29.70 7.40 7.50 32.00

Raw material

151.30 127.60 92.20 166.60 136.10

Power and fuel

- - - - -

Employee expenses

120.20 125.00 103.90 106.80 119.20

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

215.80 289.20 183.50 207.30 257.30

Provisions made

- - - - -

Depreciation

40.40 51.60 40.40 40.00 39.90

Taxation

121.70 83.40 31.60 63.80 69.90

Net profit / loss

636.30 349.10 192.00 360.20 405.30

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

35.80 35.80 35.80 35.80 35.80

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

61.69 46.92 38.11 47.53 48.05

GPM (%)

62.54 48.38 40.32 48.58 48.46

NPM (%)

49.84 34.89 29.32 37.71 38.13
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com